Cited by 978BRCA gene mutations in cancerGenetic factors in colorectal cancerPARP inhibition in cancer therapy

The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.

BRCA1 and BRCA2: 1994 and beyond

Narod, Steven A., Foulkes, William D.·2004·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

The discovery of the first gene associated with hereditary breast cancer, BRCA1, was anticipated to greatly increase our understanding of both hereditary and sporadic forms of breast cancer, and to lead to therapeutic and preventive breakthroughs. Much has been learned during the past decade about the genetic epidemiology of breast cancer, the ethnic distribution and clinical consequences of BRCA1 and BRCA2 mutations, and the central role of DNA repair in breast cancer susceptibility. The ability to translate this knowledge into novel treatments, however, remains elusive.

Integrity signals

Registry

Crossref · 10.1038/nrc1431

Cites

187 of 187 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular portraits of human breast tumours
Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Self-citation
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R. J., Parker, J. S., Hastie, T. J., Marron, J. S., Nobel, A. B., Deng, S., Johnsen, H., Pesich, R., Geisler, S. B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,508
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Self-citation
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Self-citation
Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.
Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., & Sekiya, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2766 · Cited by 3,589
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J., Lee, M. K., Newman, B. M., Morrow, J. E., Anderson, L. A., Huey, B., & King, M. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,544
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
Struewing, J., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,399

Flagged first, then by citations

Show all 187 references

Sorted by citations

Items 201–300 of 978

Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study
Conde, J., Silva, S., Azevedo, A. P., Teixeira, V., Pina, J. E., Rueff, J., & Gaspar, J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-344 · Cited by 68
The secret life of Bcl-2: Apoptosis-independent inhibition of DNA repair by Bcl-2 family members
Laulier, C., & López, B. S. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.05.002 · Cited by 70
Basal-like Breast Carcinoma: A Phenotypically Distinct Entity
Haupt, B., Ro, J. Y., & Schwartz, M. R. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.1.130 · Cited by 67
The F-box Protein FBXO44 Mediates BRCA1 Ubiquitination and Degradation
Lu, Y., Li, J., Cheng, D., Parameswaran, B., Zhang, S., Jiang, Z., Yew, P. R., Peng, J., Ye, Q., & Hu, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.407106 · Cited by 67
Quantitative phosphoproteomics reveals genistein as a modulator of cell cycle and DNA damage response pathways in triple-negative breast cancer cells
Fang, Y., Zhang, Q., Wang, X., YANG, X., Wang, X., Huang, Z., Jiao, Y., & Wang, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3327 · Cited by 65
A Novel BRCA1-Associated Protein-1 Isoform Affects Response of Mesothelioma Cells to Drugs Impairing BRCA1-Mediated DNA Repair
Parrotta, R., Okonska, A., Ronner, M., Weder, W., Stahel, R. A., Penengo, L., & Felley‐Bosco, E. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.03.023 · Cited by 65
Chromosome instability in neoplasia: chaotic roots to continuous growth
Gagos, S., & Irminger‐Finger, I. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.01.003 · Cited by 64
Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis
Schettini, F., Giudici, F., Bernocchi, O., Sirico, M., Corona, S. P., Giuliano, M., Locci, M., Paris, I., Scambia, G., Placido, S. D., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.02.035 · Cited by 65
A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival
Anjum, S., Fourkala, E.-O., Zikán, M., Wong, A., Gentry‐Maharaj, A., Jones, A., Hardy, R., Cibula, D., Kuh, D. J., Jacobs, I. J., et al. (2014) · Genome Medicine · doi:10.1186/gm567 · Cited by 66
Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers
Janysek, D. C., Kim, J. S., Duijf, P. H. G., & Dray, E. V. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101012 · Cited by 64
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru
Abugattas, J. E., Llacuachaqui, M., Allende, Y. S., Velásquez, A. A., Velarde, R. G., Cotrina, J. M., Garcés, M., León, M. L. V., Calderón, G., de la Cruz, M., et al. (2014) · Clinical Genetics · doi:10.1111/cge.12505 · Cited by 64
Self-citation
BRCA Gene Structure and Function in Tumor Suppression
Murphy, C. G., & Moynahan, M. E. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181cf0204 · Cited by 63
A whole‐genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor‐negative and ‐positive breast cancers
Natrajan, R., Mackay, A. G., Lambros, M. B. K., Weigelt, B., Wilkerson, P. M., Manié, É., Grigoriadis, A. E., A’Hern, R., van der Groep, P., Kozarewa, I., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4003 · Cited by 62
Self-citation
Hereditary breast cancer: From molecular pathology to tailored therapies
Tan, D. S. P., Marchiò, C., & Reis-Filho, J. S. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.057950 · Cited by 60
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
Na, B., Yu, X., Withers, T. A., Gilleran, J., Yao, M., Foo, T. K., Chen, C., Moore, D. F., Lin, Y., Kimball, S. D., et al. (2019) · npj Breast Cancer · doi:10.1038/s41523-019-0110-1 · Cited by 61
Application of Embryonic Lethal or Other Obvious Phenotypes to Characterize the Clinical Significance of Genetic Variants Found in Trans with Known Deleterious Mutations
Judkins, T., Hendrickson, B. C., Deffenbaugh, A. M., Eliason, K., Leclair, B., Norton, M. J., Ward, B. E., Pruss, D., & Scholl, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1241 · Cited by 62
BRCA1 and Oxidative Stress
Yi, Y. W., Kang, H. J., & Bae, I. (2014) · Cancers · doi:10.3390/cancers6020771 · Cited by 65
BRCA1 and BRCA2: The genetic testing and the current management options for mutation carriers
Palma, M., Ristori, E., Ricevuto, E., Giannini, G., & Gulino, A. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.05.003 · Cited by 61
The spectrum of mutations predisposing to familial breast cancer in Poland
Cybulski, C., Kluźniak, W., Huzarski, T., Wokołorczyk, D., Kashyap, A., Rusak, B., Stempa, K., Gronwald, J., Szymiczek, A., Bagherzadeh, M., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32492 · Cited by 62
Self-citation
The CHEK2 I157T Variant and Breast Cancer Susceptibility: A Systematic Review and Meta-analysis
Liu, C., Wang, Y., Wang, Q., & Wang, Y. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.4.1355 · Cited by 59
Biology, Metastatic Patterns, and Treatment of Patients With Triple-Negative Breast Cancer
Anders, C. K., & Carey, L. (2009) · Clinical Cancer Reviews · doi:10.3816/ccr.2009.n.005 · Cited by 59
Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance
Hofstra, R. M. W., Spurdle, A. B., Eccles, D., Foulkes, W. D., de Wind, N., Hoogerbrugge, N., Hogervorst, F. B. L., & Chenevix‐Trench, G. (2008) · Human Mutation · doi:10.1002/humu.20894 · Cited by 63
Self-citation
Integration of Steroid and Growth Factor Pathways in Breast Cancer: Focus on Signal Transducers and Activators of Transcription and Their Potential Role in Resistance
Silva, C. M., & Shupnik, M. A. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0109 · Cited by 59
Breast cancer susceptibility testing: past, present and future
Goldberg, J., & Borgen, P. I. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.8.1205 · Cited by 58
MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression
Matamala, N., Vargas, M. T., González‐Cámpora, R., Arias, J. I., Menéndez, P., Andrés‐León, E., Yanowsky, K., Llaneza-Folgueras, A., Miñambres, R., Martínez–Delgado, B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7705 · Cited by 58
Molecular Trajectory of BRCA1 and BRCA2 Mutations
Hatano, Y., Tamada, M., Matsuo, M., & Hara, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00361 · Cited by 58
Privileged Structures - Dream or Reality: Preferential Organization of Azanaphthalene Scaffold
Polański, J., Kurczyk, A., Bąk, A., & Musioł, R. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800167356 · Cited by 59
Characterization of BRCA1 Protein Targeting, Dynamics, and Function at the Centrosome
Brodie, K. M., & Henderson, B. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.327296 · Cited by 62
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Medellín, Colombia
Hernández, J. E. L., Llacuachaqui, M., Palacio, G. V., Figueroa, J. D., Madrid, J., Lema, M., Royer, R., Li, S., Larson, G. P., Weitzel, J. N., et al. (2014) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-12-11 · Cited by 57
Self-citation
Risk of colorectal cancer associated with BRCA1 and/or BRCA2 mutation carriers: systematic review and meta-analysis
Cullinane, C. M., Creavin, B., O’Connell, E., Kelly, L., O’Sullivan, M. J., Corrigan, M. A., & Redmond, H. P. (2020) · British journal of surgery · doi:10.1002/bjs.11603 · Cited by 57
BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling
Sung, M. S., & Giannakakou, P. (2013) · Oncogene · doi:10.1038/onc.2013.85 · Cited by 59
Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells
Ghosh, S., Lu, Y., Katz, A. J., Hu, Y., & Li, R. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00242.2006 · Cited by 57
A Comprehensive Review of Ovarian Serous Carcinoma
Hatano, Y., Hatano, K., Tamada, M., Morishige, K.-I., Tomita, H., Yanai, H., & Hara, A. (2019) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000243 · Cited by 56
Classifying Variants of Undetermined Significance in BRCA2 with Protein Likelihood Ratios
Karchin, R., Agarwal, M. K., Šali, A., Couch, F. J., & Beattie, M. S. (2008) · Cancer Informatics · doi:10.4137/cin.s618 · Cited by 55
Functional Classification of BRCA2 DNA Variants by Splicing Assays in a Large Minigene with 9 Exons
Acedo, A., Hernández-Moro, C., Curiel-García, Á., Díez-Gómez, B., & Velasco, E. (2015) · Human Mutation · doi:10.1002/humu.22725 · Cited by 58
RecQL4 Helicase Amplification Is Involved in Human Breast Tumorigenesis
Fang, H., Nie, L., Chi, Z., Liu, J., Guo, D. H., Lu, X., Hei, T. K., Balajee, A. S., & Zhao, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069600 · Cited by 55
Functional assays for BRCA1 and BRCA2
Carvalho, M. A., Couch, F. J., & Monteiro, Á. N. A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.08.002 · Cited by 58
Neddylation inhibits CtIP-mediated resection and regulates DNA double strand break repair pathway choice
Jimeno, S., Fernández-Ávila, M. J., Cruz-García, A., Cepeda-García, C., Gómez-Cabello, D., & Huertas, P. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1384 · Cited by 58
Testing for CHEK2 in the cancer genetics clinic: ready for prime time?
Narod, S. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01402.x · Cited by 54
Self-citation
Cyclin E expression in breast cancer: predicting germline BRCA1 mutations, prognosis and response to treatment
Chappuis, P. O., Donato, E., Goffin, J. R., Wong, N., Bégin, L. R., Kapusta, L. R., Brunet, J., Porter, P. L., & Foulkes, W. D. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi149 · Cited by 55
Self-citation
Systemic therapy options in BRCA mutation-associated breast cancer
Bayraktar, S., & Glück, S. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2158-6 · Cited by 57
Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor–coregulator interactions
Wen, J., Li, R., Lu, Y., & Shupnik, M. A. (2008) · Oncogene · doi:10.1038/onc.2008.405 · Cited by 54
Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations
Lilian Jara, S., Morales, S., de Mayo, T., González‐Hormazábal, P., Carrasco, V., & Godoy, R. (2017) · Biological Research · doi:10.1186/s40659-017-0139-2 · Cited by 57
The Role of Prophylactic Surgery in Cancer Prevention
You, Y. N., Lakhani, V. T., & Wells, S. A. (2007) · World Journal of Surgery · doi:10.1007/s00268-006-0616-1 · Cited by 54
Identification of Filamin A as a BRCA1-interacting protein required for efficient DNA repair
Velkova, A., Carvalho, M. A., Johnson, J., Tavtigian, S. V., & Monteiro, Á. N. A. (2010) · Cell Cycle · doi:10.4161/cc.9.7.11256 · Cited by 55
Global approaches to understanding ubiquitination.
Kaiser, P., & Huang, L. (2005) · Genome biology · doi:10.1186/gb-2005-6-10-233 · Cited by 54
Targeting the Akt/mTOR pathway in Brca1-deficient cancers
Xiang, T., Jia, Y., Sherris, D., Li, S., Wang, H., Lu, D., & Yang, Q. (2011) · Oncogene · doi:10.1038/onc.2010.603 · Cited by 53
The role of BRCA1 in homologous recombination repair in response to replication stress: significance in tumorigenesis and cancer therapy
Zhang, J. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-11 · Cited by 58
Targeting DNA repair in breast cancer: A clinical and translational update
Amir, E., Šeruga, B., Serrano, R., & Ocaña, A. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.03.006 · Cited by 52
Tumoral expression of BRCA1, Estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer
Roldán, G. B., Delgado, L. B., & Musé, I. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.5.2597 · Cited by 53
Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells
Alli, E., Sharma, V. B., Hartman, A., Lin, P. S., McPherson, L. A., & Ford, J. M. (2011) · BMC Pharmacology · doi:10.1186/1471-2210-11-7 · Cited by 52
The role of body size and physical activity on the risk of breast cancer in BRCA mutation carriers
Pettapiece-Phillips, R., Narod, S. A., & Kotsopoulos, J. (2015) · Cancer Causes & Control · doi:10.1007/s10552-014-0521-0 · Cited by 52
Self-citation
Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing
Mancini, J., Noguès, C., Adenis, C., Berthet, P., Bonadona, V., Chompret, A., Coupier, I., Eisinger, F., Fricker, J., Gauthier‐Villars, M., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.10.029 · Cited by 51
Breast Cancer Susceptibility and the DNA Damage Response
Đapic, V., Carvalho, M. A., & Monteiro, Á. N. A. (2005) · Cancer Control · doi:10.1177/107327480501200210 · Cited by 49
Selective degradation of PARP2 by PROTACs via recruiting DCAF16 for triple-negative breast cancer
Pu, C., Tong, Y., Liu, Y., Lan, S., Wang, S., Yan, G., Zhang, H., Luo, D., Ma, X., Yu, S., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114321 · Cited by 54
Improvement in DCIS Detection Rates by MRI Over Time in a High-Risk Breast Screening Study
Warner, E., Causer, P. A., Wong, J. W., Wright, F. C., Jong, R. A., Hill, K. A., Messner, S. J., Yaffe, M. J., Narod, S. A., & Plewes, D. B. (2011) · The Breast Journal · doi:10.1111/j.1524-4741.2010.01018.x · Cited by 50
Self-citation
Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival
Liu, J. F., Cristea, M. C., Frankel, P. H., Neuhausen, S. L., Steele, L., Engelstaedter, V., Matulonis, U. A., Sand, S. R., Tung, N., Garber, J. E., et al. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.01.008 · Cited by 54
Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression
Templeton, A. J., Gonzalez, L. D., Vera-Badillo, F., Tibau, A., Goldstein, R., Šeruga, B., Srikanthan, A., Pandiella, A., Amir, E., & Ocaña, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154789 · Cited by 53
Targeting progesterone signaling prevents metastatic ovarian cancer
Kim, O., Park, E. Y., Kwon, S. Y., Shin, S., Emerson, R. E., Shin, Y.-H., DeMayo, F. J., Lydon, J. P., Coffey, D. M., Hawkins, S. M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013595117 · Cited by 50
DNA-PKcs activates the Chk2–Brca1 pathway during mitosis to ensure chromosomal stability
Shang, Z., Yu, L., Lin, Y., Matsunaga, S., Shen, C.-Y., & Chen, B. (2014) · Oncogenesis · doi:10.1038/oncsis.2013.49 · Cited by 53
Triple negative breast cancer: new therapeutic approaches and BRCA status
Eskiler, G. G., Çeçener, G., Egelí, Ü., & Tunca, B. (2018) · Apmis · doi:10.1111/apm.12836 · Cited by 49
Augmentation of the antitumor effects of PARP inhibitors in triple-negative breast cancer via degradation by hydrophobic tagging modulation
Go, A., Jang, J. W., Lee, W., Ha, J. D., Kim, H. J., & Nam, H. J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112635 · Cited by 49
Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families
Manoukian, S., Peissel, B., Pensotti, V., Barile, M., Cortesi, L., Stacchiotti, S., Terenziani, M., Barbera, F., Pasquini, G., Frigerio, S., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2006.09.024 · Cited by 48
Cellular Mechanisms Underlying Intertumoral Heterogeneity
Sutherland, K. D., & Visvader, J. E. (2015) · Trends in cancer · doi:10.1016/j.trecan.2015.07.003 · Cited by 50
Triple-Negative Breast Cancer: Clinical and Histological Correlations
Elsawaf, Z. M., & Sinn, H. (2011) · Breast Care · doi:10.1159/000331643 · Cited by 48
Coffee Consumption and CYP1A2*1F Genotype Modify Age at Breast Cancer Diagnosis and Estrogen Receptor Status
Bågeman, E., Ingvar, C., Rose, C., & Jernström, H. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0555 · Cited by 48
Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark
Thomassen, M., Gerdes, A., Crüger, D. G., Jensen, P. K. A., & Kruse, T. A. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.12.016 · Cited by 48
Differential effects of poly(ADP-ribose) polymerase inhibition on DNA break repair in human cells are revealed with Epstein–Barr virus
Ma, W., Halweg, C., Menéndez, D., & Resnick, M. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118078109 · Cited by 46
Causal Reasoning on Boolean Control Networks Based on Abduction: Theory and Application to Cancer Drug Discovery
Biane, C., & Delaplace, F. (2018) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2018.2889102 · Cited by 50
Preclinical mouse models for BRCA1-associated breast cancer
Drost, R., & Jonkers, J. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605350 · Cited by 48
MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish–Ashkenazi descent
Yarden, R. I., Friedman, E., Metsuyanim, S., Olender, T., Ben‐Asher, E., & Papa, M. Z. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9797-z · Cited by 47
Cell cycle arrest and induction of apoptosis by cajanin stilbene acid from Cajanus cajan in breast cancer cells
Fu, Y., Kadioglu, O., Wiench, B., Wei, Z., Gao, C., Luo, M., Gu, C., Zu, Y., & Efferth, T. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.02.005 · Cited by 46
FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer
Gong, C., Fujino, K., Monteiro, L. J., Gomes, A., Drost, R., Davidson‐Smith, H., Takeda, S., Khoo, U., Jonkers, J., Sproul, D., et al. (2014) · Oncogene · doi:10.1038/onc.2014.421 · Cited by 46
The role of BRCA1/2 in hereditary and familial breast and ovarian cancers
Hawsawi, Y. M., Al‐Numair, N. S., Sobahy, T. M., Al‐Ajmi, A. M., Al‐Harbi, R. M., Baghdadi, M. A., Oyouni, A. A. A., & Al‐Amer, O. M. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.879 · Cited by 49
Stem Cells and the Developing Mammary Gland
Makarem, M., Spike, B. T., Dravis, C., Kannan, N., Wahl, G. M., & Eaves, C. J. (2013) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-013-9284-6 · Cited by 49
Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system
Bellcross, C. A., Peipins, L. A., McCarty, F., Rodriguez, J. L., Hawkins, N. A., Alford, S. H., & Leadbetter, S. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.68 · Cited by 44
RAP80 Protein Is Important for Genomic Stability and Is Required for Stabilizing BRCA1-A Complex at DNA Damage Sites in Vivo
Wu, J., Liu, C., Chen, J., & Yu, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.351007 · Cited by 48
Full-Exon Pyrosequencing Screening of BRCA Germline Mutations in Mexican Women with Inherited Breast and Ovarian Cancer
Vaca‐Paniagua, F., Álvarez-Gómez, R. M., Fragoso‐Ontiveros, V., Vidal-Millán, S., Herrera, L. A., de León, D. F. C., Bargalló‐Rocha, E., Mohar, A., López‐Camarillo, C., & Pérez‐Plasencia, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037432 · Cited by 45
Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and p53
Quinn, B. A., Brake, T., Xiang, H., Baxter-Jones, K., Litwin, S., Ellenson, L. H., & Connolly, D. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008404 · Cited by 46
Dietary intake and breast cancer among carriers and noncarriers of BRCA mutations in the Korean Hereditary Breast Cancer Study
Ko, K., Kim, S., Ma, S. H., Park, B., Ahn, Y., Lee, J. W., Lee, M. H., Kang, E., Kim, L. S., Jung, Y. S., et al. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.057760 · Cited by 45
Cancer Risk Assessment Using Genetic Panel Testing: Considerations for Clinical Application
Hiraki, S. C., Rinella, E. S., Schnabel, F. R., Oratz, R., & D, H. O. M. (2014) · Journal of Genetic Counseling · doi:10.1007/s10897-014-9695-6 · Cited by 49
Genetic testing for RAD51C mutations: in the clinic and community
Sopik, V., Akbari, M. R., & Narod, S. A. (2014) · Clinical Genetics · doi:10.1111/cge.12548 · Cited by 48
Self-citation
ASTE1 promotes shieldin-complex-mediated DNA repair by attenuating end resection
Zhao, F., Kim, W., Gao, H., Liu, C., Zhang, Y., Chen, Y., Deng, M., Zhou, Q., Huang, J., Hu, Q., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00723-9 · Cited by 47
Eighty percent of proteins are different between humans and chimpanzees
Glazko, G. V., Veeramachaneni, V., Nei, M., & Makałowski, W. (2005) · Gene · doi:10.1016/j.gene.2004.11.003 · Cited by 45
Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors
Yao, H., Ji, M., Zhu, Z., Zhou, J., Cao, R., Chen, X., & Xu, B. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.12.071 · Cited by 44
MRI in the Early Detection of Breast Cancer in Women with High Genetic Risk
Trecate, G., Vergnaghi, D., Manoukian, S., Bergonzi, S., Scaperrotta, G. P., Marchesini, M., Ferranti, C., Peissel, B., Spatti, G., Böhm, S., et al. (2006) · Tumori Journal · doi:10.1177/030089160609200609 · Cited by 44
Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1
Carvalho, M. A., Pino, M. A., Karchin, R., Beddor, J., Godinho-Netto, M., Mesquita, R. D., Rodarte, R. S., Vaz, D. C., Monteiro, V. A., Manoukian, S., et al. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.09.017 · Cited by 43
Pir51, a Rad51-interacting protein with high expression in aggressive lymphoma, controls mitomycin C sensitivity and prevents chromosomal breaks
Henson, S. E., Tsai, S.-C., Malone, C. S., Soghomonian, S. V., Ouyang, Y., Wall, R., Marahrens, Y., & Teitell, M. A. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.06.016 · Cited by 40
Up-regulation of miR-1245 by c-myc targets BRCA2 and impairs DNA repair
Song, L., Dai, T., Xie, Y., Wang, C., Lin, C., Wu, Z., Ying, Z., Wu, J., Li, M., & Li, J. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjr046 · Cited by 44
Chromatin Remodeling in Mammary Gland Differentiation and Breast TumorigenesisPreprint
Huang, T. H. ‐., & Esteller, M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004515 · Cited by 42
Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges
Πουμπουρίδου, Ν., & Κroupis, C. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2011-0840 · Cited by 43
Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide
Wang, X., Gao, P., Long, M., Fang, L., Wei, J., Ren, J.-H., Lin, Y., He, T., Han, Y., & Zhang, H. (2010) · Medical Oncology · doi:10.1007/s12032-010-9552-x · Cited by 42
Genotype-phenotype relationship between DNA repair gene genetic polymorphisms and DNA repair capacity.
Shin, A., Lee, K.-M., Ahn, B., Park, C., Noh, S.-K., Park, D.-Y., Ahn, S. H., Yoo, K.-Y., & Kang, D. (2008) · PubMed · Cited by 42
Bcl-2 Inhibits Nuclear Homologous Recombination by Localizing BRCA1 to the Endomembranes
Laulier, C., Barascu, A., Guirouilh‐Barbat, J., Pennarun, G., Chalony, C. L., Chevalier, F., Palierne, G., Bertrand, P., Verbavatz, J., & López, B. S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3119 · Cited by 49
Antibody Arrays in Biomarker Discovery
Wilson, J. J., Burgess, R., Mao, Y., Luo, S., Tang, H., Jones, V. S., Bao, W., Huang, R.-Y., Chen, X., & Huang, R.-P. (2015) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.01.002 · Cited by 42
Genomics of adaptive evolution in the woolly mammoth
Díez‐del‐Molino, D., Dehasque, M., Chacón-Duque, J. C., Pečnerová, P., Tikhonov, A., Protopopov, A. V., Плотников, В. В., Kanellidou, F., Nikolskiy, P. A., Mortensen, P. B., et al. (2023) · Current Biology · doi:10.1016/j.cub.2023.03.084 · Cited by 43
USP-11 as a Predictive and Prognostic Factor Following Neoadjuvant Therapy in Women With Breast Cancer
Bayraktar, S., Gutierrez‐Barrera, A. M., Liu, D., Pusztai, L., Litton, J. K., Valero, V., Hunt, K. K., Hortobágyi, G. N., Wu, Y., Symmans, W. F., et al. (2013) · The Cancer Journal · doi:10.1097/ppo.0b013e3182801b3a · Cited by 41
Genetic Cancer Risk Assessment for Breast Cancer in Latin America
Chávarri-Guerra, Y., Blazer, K. R., & Weitzel, J. N. (2017) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.17002195 · Cited by 41
A yeast recombination assay to characterize humanBRCA1missense variants of unknown pathological significance
Caligo, M. A., Bonatti, F., Guidugli, L., Aretini, P., & Galli, A. (2008) · Human Mutation · doi:10.1002/humu.20817 · Cited by 41
A case report of quadruple cancer in a single patient including the breast, rectum, ovary, and endometrium
Noh, S.-K., Yoon, J. Y., Ryoo, U. N., Choi, C. H., Sung, C. O., Kim, T. J., Bae, D., & Kim, B. (2008) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2008.19.4.265 · Cited by 41

Authors: Narod, S. A., & Foulkes, W. D.
Affiliations: Sunnybrook Health Science Centre (CA)
McGill University (CA)
Corresponding author: Narod, Steven A.
ORCID: Narod, Steven A.
Foulkes, William D.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2004-09
Volume: 4
Issue: 9
Pages: 665-676
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1431
OpenAlex: W2091961739
Cited by: 967
References: 187
Citations by year: 2026: 13 · 2025: 29 · 2024: 30 · 2023: 37 · 2022: 36 · 2021: 40 · 2020: 30 · 2019: 31 · 2018: 33 · 2017: 35 · 2016: 38 · 2015: 53 · 2014: 38 · 2013: 43 · 2012: 59
FWCI: 6.57
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Keywords: BRCA1, BRCA2, hereditary breast cancer, genetic susceptibility, DNA repair, genetic epidemiology, breast cancer prevention, breast cancer treatment
MeSH terms: Breast Neoplasms, DNA Damage, DNA Repair, Female, Humans, Mutation, Molecular Epidemiology, Genes, BRCA1, Genetic Predisposition to Disease, Genes, BRCA2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

BRCA1 and BRCA2: 1994 and beyond

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks